NASDAQ:CATB
Delisted
Catabasis Pharmaceuticals Stock News
$3.36
+0.195 (+6.16%)
At Close: May 27, 2022
Catabasis Renames As Astria Therapeutics With New Disease Focus
02:37pm, Wednesday, 08'th Sep 2021
Once-struggling, Catabasis Pharmaceuticals Inc (NASDAQ: CATB) is looking to hit the reset button with a new name and focus. Catabasis has been dragging for several years, weighed down mainly by the
Catabasis Pharmaceuticals Shares: 1-For-6 Split Goes Into Effect
02:07pm, Friday, 20'th Aug 2021
Catabasis Pharmaceuticals Inc (NASDAQ: CATB) deployed a reverse stock split of its shares of common stock at a ratio of 1-for-6. These are the details.
Catabasis Pharmaceuticals: Transformation Through Quellis Biosciences Acquisition
02:24am, Wednesday, 30'th Jun 2021
Catabasis Pharmaceuticals: Transformation Through Quellis Biosciences Acquisition
CATB Stock Price Increases Over 40% Pre-Market: Why It Happened
04:42am, Wednesday, 16'th Jun 2021
The stock price of Catabasis Pharmaceuticals Inc (NASDAQ: CATB) increased by over 40% pre-market. This is why it happened.
Catabasis Pharmaceuticals To Present At Upcoming Investor Conferences
08:00am, Friday, 14'th May 2021
BOSTON--(BUSINESS WIRE)--Catabasis Pharmaceuticals To Present At Upcoming Investor Conferences
Catabasis Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides a Corporate Update
04:10pm, Thursday, 11'th Mar 2021
BOSTON--(BUSINESS WIRE)--Catabasis Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides a Corporate Update
AEP, Oracle, Tesla and More Thursday Afternoon Analyst Calls
12:14pm, Thursday, 11'th Mar 2021
With the trading day halfway over, the broad markets were making yet another strong push.
Catabasis Pharmaceuticals To Present At Upcoming Investor Conferences
08:00am, Tuesday, 02'nd Mar 2021
BOSTON--(BUSINESS WIRE)--Catabasis Pharmaceuticals To Present At Upcoming Investor Conferences.
CATB Stock: Why Catabasis Pharma Stock Is Skyrocketing Today
10:46am, Friday, 29'th Jan 2021
Catabasis Pharma (CATB) stock is soaring higher on Friday after announcing its acquisition of Quellis Biosciences and a PIPE. The post CATB Stock: Why Catabasis Pharma Stock Is Skyrocketing Today appe
Catabasis Pharmaceuticals: 9 Things for Potential CATB Stock Investors to Know
12:12pm, Wednesday, 02'nd Dec 2020
Catabasis Pharmaceuticals (CATB) stock is taking off on Wednesday despite a lack of news from the biopharmaceutical company. The post Catabasis Pharmaceuticals: 9 Things for Potential CATB Stock Inves
Catabasis Pharmaceuticals News: Why CATB Stock Is Plummeting 69% Today
11:17am, Tuesday, 27'th Oct 2020
Catabasis Pharmaceuticals (CATB) news for Tuesday includes incredibly poor results from a clinical trial hammering CATB stock hard. The post Catabasis Pharmaceuticals News: Why CATB Stock Is Plummetin
SAB Biotherapeutics annonce le dosage du premier patient de l’essai clinique de phase 1b de SAB-185 pour le traitement du COVID-19
12:00am, Saturday, 22'nd Aug 2020
SAB Biotherapeutics announces the first patient dosed in its Phase 1B study evaluating SAB-185, the second study initiated this month for COVID-19.
Dentistry – your ticket around the globe? Part three – Dentistry Online
06:06am, Friday, 14'th Aug 2020
Thinking of moving abroad? Roshan Bains explores what requirements dentists need to practise elsewhere. In part two, he looks at UAE and Singapore.
Catabasis Pharmaceuticals (CATB) Gets a Buy Rating from Oppenheimer - Markets
02:30pm, Tuesday, 11'th Aug 2020
In a report released today, Hartaj Singh from Oppenheimer maintained a Buy rating on Catabasis Pharmaceuticals (CATB – Research Report),
SAB Biotherapeutics (SAB), a clinical stage biopharmaceutical company developing a novel immunotherapy platform to produce specifically targeted, high
